✦ LIBER ✦

Pituitary Ischemic Apoplexy in a Young Woman Using Oral Contraceptives: A Case Report

✍ Scribed by Kobayashi, Junpei; Miyashita, Kotaro; Tamanaha, Tamiko; Kobayashi, Norikata; Iihara, Koji; Nagatsuka, Kazuyuki

Book ID: 123139914
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 128 KB
Volume: 22
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster 200: Severe headache in a woman u

Poster 200: Severe headache in a woman using oral contraceptives: a case report.

✍ Sheila A. Dugan; Robin L. Wellington 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 29 KB

Pituitary Apoplexy in a Teenager—Case Re

Pituitary Apoplexy in a Teenager—Case Report

✍ Chao, Chen-Cheng; Lin, Chun-Ju 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 834 KB

Oral contraceptive exposure in a male wi

Oral contraceptive exposure in a male with a pituitary microadenoma: a case report

✍ G.C. Buchanan; D.R. Tredway; S.B. Lewis 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Stroke associated with pituitary apoplex

Stroke associated with pituitary apoplexy in a giant prolactinoma: A case report

✍ Navarro-Bonnet, Jorge; Martínez-Anda, Jaime Jesús; Balderrama-Soto, Adriana; Pér 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Ischemic colitis and acquired resistance

Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives

✍ David E Mann Jr.; Evelyn R Kessel; Diane L Mullins; Richard Lottenberg 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

Hepatocellular carcinoma in a young woma

Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives

✍ Gattanell, Perry N. ;Perloff, Marjorie ;Holland, James F. 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 989 KB

A case of hepatocellular carcinoma in a young female is presented in which the apparent etiology was the use of oral contraceptives for 5 1/2 years. Sequential therapeutic trials with intraarterial 5-fluorouracil, intraarterial adriamycin, and intravenous 1,3 bis[2-chloroethyl]-1-nitrosourea (BCNU)